These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22985910)

  • 1. Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.
    Taremi M; Hope A; Lindsay P; Dahele M; Fung S; Purdie TG; Jaffray D; Dawson L; Bezjak A
    Radiat Oncol; 2012 Sep; 7():159. PubMed ID: 22985910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
    Pettersson N; Nyman J; Johansson KA
    Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
    Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
    Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivered dose-effect analysis of radiation induced rib fractures after thoracic SBRT.
    Juan-Cruz C; Stam B; Belderbos J; Sonke JJ
    Radiother Oncol; 2021 Sep; 162():18-25. PubMed ID: 34166718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer.
    Miura H; Inoue T; Shiomi H; Oh RJ
    J Radiat Res; 2015 Mar; 56(2):332-7. PubMed ID: 25504640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.
    Asai K; Shioyama Y; Nakamura K; Sasaki T; Ohga S; Nonoshita T; Yoshitake T; Ohnishi K; Terashima K; Matsumoto K; Hirata H; Honda H
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):768-73. PubMed ID: 22445398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Manyam BV; Videtic GMM; Verdecchia K; Reddy CA; Woody NM; Stephans KL
    Pract Radiat Oncol; 2019 Mar; 9(2):e187-e195. PubMed ID: 30529796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer.
    Abe T; Shirai K; Saitoh J; Ebara T; Shimada H; Tashiro M; Okano N; Ohno T; Nakano T
    Acta Oncol; 2016; 55(2):163-6. PubMed ID: 26399488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors.
    Nambu A; Onishi H; Aoki S; Tominaga L; Kuriyama K; Araya M; Saito R; Maehata Y; Komiyama T; Marino K; Koshiishi T; Sawada E; Araki T
    BMC Cancer; 2013 Feb; 13():68. PubMed ID: 23391264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative rib fracture risk after stereotactic body radiotherapy in patients with localized non-small cell lung cancer.
    Bentsen KK; Brink C; Nielsen TB; Lynggaard RB; Vinholt PJ; Schytte T; Hansen O; Jeppesen SS
    Radiother Oncol; 2024 Nov; 200():110481. PubMed ID: 39159679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
    Park Y; Kim HJ; Chang AR
    Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possibility of chest wall dose reduction using volumetric-modulated arc therapy (VMAT) in radiation-induced rib fracture cases: comparison with stereotactic body radiation therapy (SBRT).
    Murakami Y; Nakano M; Yoshida M; Hirashima H; Nakamura F; Fukunaga J; Hirose TA; Yoshioka Y; Oguchi M; Hirata H
    J Radiat Res; 2018 May; 59(3):327-332. PubMed ID: 29800456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry.
    Coroller TP; Mak RH; Lewis JH; Baldini EH; Chen AB; Colson YL; Hacker FL; Hermann G; Kozono D; Mannarino E; Molodowitch C; Wee JO; Sher DJ; Killoran JH
    PLoS One; 2014; 9(4):e94859. PubMed ID: 24728448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.
    Mutter RW; Liu F; Abreu A; Yorke E; Jackson A; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1783-90. PubMed ID: 21868173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer.
    Voroney JP; Hope A; Dahele MR; Purdie TG; Franks KN; Pearson S; Cho JB; Sun A; Payne DG; Bissonnette JP; Bezjak A; Brade AM
    J Thorac Oncol; 2009 Aug; 4(8):1035-7. PubMed ID: 19633478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
    Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
    J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.
    Bongers EM; Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
    J Thorac Oncol; 2011 Dec; 6(12):2052-7. PubMed ID: 22052227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
    Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.